Pressure Ulcers Stage III Clinical Trial
Official title:
The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for the Treatment of Pressure Ulcers
To investigate whether an oral nutritional supplement of a mixture of arginine, glutamine and HMB for a maximum period of four weeks is more beneficial than the standard dietary approach to the healing of pressure ulcers, and to examine whether the use of it can reduce admissions and length of hospitalizations for these patients.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | March 31, 2020 |
Est. primary completion date | September 30, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Inpatients of medical and geriatric wards of OLMH and WTSH 2. Aged 18 and older with stage III - IV lesions 3. Patients fed orally or through feeding tubes were included Exclusion Criteria: 1. Patients with history of using the nutritional supplement (ABOUND) in previous three months 2. Patients with cellulitis, wounds with purulent discharge or osteomyelitis or sepsis 3. Patients requiring protein restriction 4. Patients with poorly controlled diabetes mellitus (latest HbA1C > 8.5) (healing process may be affected 5. Patients under palliative care |
Country | Name | City | State |
---|---|---|---|
Hong Kong | Our Lady of Maryknoll Hospital | Wong Tai Sin |
Lead Sponsor | Collaborator |
---|---|
Our Lady of Maryknoll Hospital | Wong Tai Sin Hospital |
Hong Kong,
Cereda E, Gini A, Pedrolli C, Vanotti A. Disease-specific, versus standard, nutritional support for the treatment of pressure ulcers in institutionalized older adults: a randomized controlled trial. J Am Geriatr Soc. 2009 Aug;57(8):1395-402. doi: 10.1111/j.1532-5415.2009.02351.x. — View Citation
Cereda E, Klersy C, Serioli M, Crespi A, D'Andrea F; OligoElement Sore Trial Study Group.. A nutritional formula enriched with arginine, zinc, and antioxidants for the healing of pressure ulcers: a randomized trial. Ann Intern Med. 2015 Feb 3;162(3):167-74. doi: 10.7326/M14-0696. Erratum in: Ann Intern Med. 2015 Dec 15;163(12):964. — View Citation
Wong A, Chew A, Wang CM, Ong L, Zhang SH, Young S. The use of a specialised amino acid mixture for pressure ulcers: a placebo-controlled trial. J Wound Care. 2014 May;23(5):259-60, 262-4, 266-9. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | percentage change in pressure ulcer area | 4 weeks | ||
Primary | change in Pressure Ulcer Scale for Healing (PUSH) | 4 weeks | ||
Secondary | number of hospital admissions | six months | ||
Secondary | length of hospitalisation | six months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04311229 -
Effectiveness of Negative-Pressure Wound Therapy
|
N/A | |
Recruiting |
NCT05894291 -
Comparaison of Two Prone Position Techniques on Occurence of Pressure Sores in ICU
|
N/A | |
Completed |
NCT02222454 -
Safety Evaluation of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers
|
N/A | |
Not yet recruiting |
NCT05649332 -
Study to Evaluate the Performance and Safety of the Medical Device Argogen
|
N/A | |
Completed |
NCT05130814 -
EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers
|
N/A | |
Recruiting |
NCT05496296 -
Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
|
N/A | |
Completed |
NCT03283787 -
Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytalâ„¢ to Standard of Care in Stage 3 or 4 Pressure Injuries
|
N/A |